Michelle Lavin, MD, PhD

Consultant Haematologist
National Coagulation Centre, St. James Hospital and Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Physicians and Surgeons in Ireland (RCSI)

Dr. MIchelle Lavin (MB, PhD, FRCPath) is a Consultant Haematologist at the National Coagulation Centre, Dublin with research based in the Irish Centre for Vascular Biology, RCSI, Dublin. Her research focuses on the impact of bleeding disorders particularly on Women and Girls with Bleeding Disorders (WGBD), the use of bleeding assessment tools and understanding the phenotypic variability in bleeding disorders. She serves as the Chair of the VWD and Rare Bleeding Disorder Committee of the World Federation of Haemophilia (WFH) and a Co-Chair on the European Association for Haemophilia and Allied Disorders (EAHAD) WGBD Committee.

Presentation(s):

• SSC 05.10 - Where Do We Go From Here? Call to Action on Research Priorities in Bleeding Disorder of Unknown Cause (BDUC)

  Saturday, July 9, 2022
  4:05 PM – 4:20 PM

• SSC 08.11 - Q&A

  Sunday, July 10, 2022
  6:10 PM – 6:25 PM

• PB0810 - A novel role for subtle enhanced VWF clearance in Low VWF pathogenesis highlights limitations of VWFpp/VWF:Ag ratio assessment of clearance.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 52.6 - Bleeding and Thrombotic Complications in Women’s Health

  Tuesday, July 12, 2022
  10:45 AM – 12:00 PM

• OC 63.2 - Inter-individual FVIII clearance heterogeneity in PWH in the iPATH study – biological determinants and clinical importance.

  Tuesday, July 12, 2022
  3:00 PM – 3:15 PM

• PB1244 - Development of Consensus on Standardized Nomenclature for PT-VWD- Joint Project from the ISTH SSCs on Platelet Physiology, VWF and Genomics in thrombosis and Haemostasis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM